CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1980; 30:2-15
doi: 10.3322/canjclin.30.1.2
© 1980 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, H. R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barber, H. R. K.

CA: A Cancer Journal for Clinicians, Vol 30, 2-15, Copyright © 1980 by American Cancer Society

Ovarian Cancer, Part II

Hugh R. K. Barber M.D.1

1 Director, Department of Obstetrics and Gynecology, Lenox Hill Hospital; Consultant, Gynecologic Service, Memorial Hospital for Cancer and Allied Diseases; Attending Obstetrician-Gynecologist, New York Hospital; Clinical Professor of Obstetrics and Gynecology, Cornell Medical College; and Professor and Chairman of Obstetrics and Gynecology of the New York Medical College, New York, New York.

Early diagnosis is the most effective means of reducing the currently high mortality rate associated with ovarian cancer. The palpation of what appears to be a normal size ovary in a premenopausal woman suggests an ovarian tumor in a postmenopausal woman. Also, rule out ovarian cancer in any 40-year or older woman who presents with persistent, unexplained gastrointestinal symptoms. Ninety percent of all ovarian tumors are of epithelial origin. Treatment consists of total hysterectomy, bilateral salpingo-oophorectomy, omentectomy and appendectomy. P32 instillation is optional. In Stages IIb, III and IV chemotherapy is advised, while in Stages I and IIa the use of prophylactic chemotherapy must be judged on an individual basis.

Ovarian cancer in children that is beyond the localized stage is one of the most frustrating of all gynecologic diseases. Total surgical extirpation of localized disease is the only hope for cure and, as yet, early diagnosis is more chance than scientific method.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by American Cancer Society.